relapsed or refractory B cell lymphoma

FDA clears IND for Verismo Therapeutics’ CAR-T therapy
Clinical Trials Arena
Wed, 05/15/24 - 11:29 am
Verismo Therapeutics
CAR-T SynKIR-310
FDA
clinical trials
relapsed or refractory B cell lymphoma
3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond
Motley Fool
Fri, 07/28/23 - 10:38 am
Caribou Biosciences
cell therapy
CB-010
relapsed or refractory B cell lymphoma